Incidence of cardiovascular events in giant cell arteritis: Preliminary results of a prospective double cohort study (GRACG);Incidence des accidents cardiovasculaires au cours de la maladie de Horton: Résultats préliminaires de l'étude prospective en double cohorte GRACG

Revue de Medecine Interne

Volumn 27, Issue 2, 2006, Pages 98-105

  Le Page, L ^a   Duhaut, P ^a   Seydoux, D ^b   Bosshard, S ^c   Ecochard, R ^d   Abbas, F ^d   Petigny V ^a   Cevallos, R ^a   Smail, A ^a   Salle, V ^a   Chatelain, D ^a   Loire, R ^e   Pellet, H ^c   Piette, J C ^f   Ducroix, J P ^a  

^a AMIENS UNIVERSITY HOSPITAL   (France)

^b Soc de Secours Miniere de la Loire   (France)

^c UNIVERSITÉ LYON 1   (France)

^d HOSPICES CIVILS DE LYON   (France)

^e LOUIS PRADEL HOSPITAL   (France)

^f PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Cardiovascular events; Cohort study; Giant cell arteritis

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GIANT CELL ARTERITIS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INCIDENCE; ISCHEMIC HEART DISEASE; LOG RANK TEST; MALE; PARAMETER; PERIPHERAL VASCULAR DISEASE; POPULATION RESEARCH; SURVIVAL;

AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RISK FACTORS; TEMPORAL ARTERITIS;

EID: 31944445952     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2005.10.009     Document Type: Article

References (39)

1. C.R. Morris, and J.S. Scheib Fatal myocardial infarction resulting from coronary arteritis in a patient with polymyalgia rheumatica and biopsy proved temporal arteritis. A case report and review of the literature Arch Intern Med 154 1994 1158 1160
2. T. Le Tourneau, B. Agraou, J.P. Beregi, C.A. Maurage, and E.P. Asseman Cardiovascular manifestations of Horton disease: un underestimated disease in cardiology Arch Mal Coeur Vaiss 90 1997 1403 1407
3. M.A. Gonzalez-Gay, G. Rubiera, A. Pineiro, C. Garcia-Porrua, R. Pego-Eeigosa, and C. Gonzalez-Juanatey Ischemic heart disease in patients from Northwest Spain with biopsy proven giant cell arteritis. A population base study J. Rheumatol 33 2005 502 506
4. T. Buttner, N. Heye, and H. Przuntek Temporal arteritis with cerebral comllications: report of four cases Eur Neurol 34 1994 162 167
5. J. Collazos, C. Garcia-Monco, A. Martin, J. Rodriguez, and M.A. Gomez Multiple strokes after initiation of steroid therapy in gian cell arteritis Postgrad Med J 70 1994 228 230
6. M.A. Gonzalez-Gay, R. Blanco, V. Rodriguez-Valverde, V.M. Martinez-Taboada, M. Delgado-Rodriguez, and M. Uriarte Permanent visual loss and cerebrovascular accidents in giant cell arteritis. Predictors andresponse to treatment Arthritis Rheum 41 1998 1497 1504
7. G. Nesher Neurologic manifestations of giant cell arteritis Clin Exp Rheumatol 18 2000 S24 S26
8. G. Nesher, Y. Berkun, M. Mates, M. Baras, R. Nesher, and A. Rubinow Risk factors for cranial ischemic complications in giant cell arteritis Medicine 83 2004 114 122
9. G. Nesher, Y. Berkun, M. Mates, M. Baras, and A. Rubinow Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis Arthritis Rheum 50 2004 1332 1337
10. J. Stokes, W.B. Kannel, P.A. Wolf, R.B. D'Agostino, and L.A. Cupples Blood pressure as a risk factor for cardiovascular disease. The Framingham Study-30 years of follow-up Hypertension 13 1989 I13 I18
11. F.N. Brand, R.D. Abbott, and W.B. Kannel Diabetes, intermittent claudication, and risk of cardiovascular events. The Framingham Study Diabetes 38 1989 504 509
12. W.B. Kannel, and D.L. McGee Diabetes and cardiovascular risk factors. The Framingham Study Circulation 59 1979 8 13
13. P.W. Wilson, R.D. Abbott, and W.P. Castelli High density lipoprotein cholesterol and mortality. The Framingham Heart Study Arteriosclerosis 8 1988 737 741
14. P.A. Wolf, R.B. D'Agostino, W.B. Kannel, R. Bonita, and A.J. Belanger Cigarette smoking as a risk factor for stroke. The Framingham Study JAMA 259 1988 1025 1029
15. S.M. Grundy Assessment of cardiovascular risk by use of multiple-risk factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology Circulation 100 1999 1481 1492
16. D. Wood Established and emerging cardiovascular risk factors Am Heart J 141 2001 S49 S57
17. G. De Backer, E. Ambrosioni, K. Borch-Johnsen, C. Brotons, R. Cifkova, and J. Dallongeville European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and other societies on cardiovascular disease prevention in clinical practice. Executive summary Eur Heart J 24 2003 1601 1610
18. Agence nationale d'accŕditation et d'́valuation en sant́ Ḿthode d'́valuation du risque cardio-vasculaire global 2004 ANAES Paris
19. H.B. Hubert, M. Feinleib, P.M. McNamara, and W.P. Castelli Obesity as an independent risk factor for cardiovascular disease; a 26-year follow-up of participants in the Framingham Study Circulation 67 1983 968 977
20. A. Liem, G.H. Reynierse-Buitenwerf, A.H. Zwinderman, J.W. Jukema, and D.J. Van Veldhuisen Secondary prevention with folic acid: effects on clinical outcomes J Am Coll Cardiol 41 2003 2105 2113
21. V. Janardhan, P.A. Wolf, C.S. Kase, J.M. Masaro, R.B. D'Agostino, and C. Franzblau Anticardiolipin antibodies and risk of ischemic stroke and transient ischemic attack: the Framinghan cohort and offspring study Stroke 35 2004 736 741
22. E.B.V. Machado, C.J. Michet, D.J. Ballard, G.G. Hunder, C.M. Beard, and C.P. Chu Trends in incidence and clinical presentation of temporal arteritis in Olmsted county, Minnessota, 1950-1985 Arthritis and rheum 31 1988 745 749
23. P. Duhaut, L. Pinede, S. Demolombe-Rague, R. Loire, and D. Seydoux Giant cell arteritis and cardiovascular risk factors: a multicenter prospective case-control study. Groupe de Recherche sur l'Art́rite ̀ Cellules Ǵantes Arthritis Rheum 41 1998 1960 1965
24. P. Duhaut, M. Berruyer, L. Pinede, S. Demolombe-Rague, R. Loire, and D. Seydoux Anticardiolipin antibodies and giant cell arteritis: a prospective, multicenter case-control study. Groupe de Recherche sur l'Art́rite ̀ Cellules Ǵantes Arthritis Rheum 41 1998 701 709
25. E. Liozon, V. Roussel, P. Roblot, F. Liozon, J.L. Preud'Homme, and V. Loustaud Absence of anti-beta2 glycoprotein I antibodies in giant cell arteritis: a study of 45 biopsy-proven cases Br J Rheumatol 37 1998 1129 1931
26. E. Nordborg, and B.-A. Bengtsson Death rates and causes of death in 284 consecutive patients with giant cell arteritis confirmed by biopsy BMJ 299 1989 549 550
27. G. Nesher, M. Sonnenblick, and Y. Friedlander Analysis of steroid related complications and mortality in temporal arteritis: a 15-year survey of 43 patients J Rheumatol 21 1994 1283 1286
28. C. Bisgard, H. Sloth, N. Keiding, and K. Juel Excess mortality in giant cell arteritis J Intern Med 230 1991 119 123
29. E. Graham, A. Holland, A. Avery, and R.W. Russel Prognosis in giant-cell arteritis BMJ 282 1981 269 271
30. J.T. Gran, G. Myklebust, T. Wilsgaard, and B.K. Jacobsen Survival in polymyalgia rheumatica and temporal arteritis: a study of 398 cases and matched population controls Rheumatology 40 2001 1238 1242
31. A. Uddhammar, A.L. Eriksson, L. Nystrom, R. Stenling, and S. Rantapaa-Dah Increased mortality due to cardiovascular disease in patients with giant cell arteritis in northen Sweden J Rheumatol 29 2002 737 742
32. R. Andersson, B.E. Malmvall, and B.-A. Bentgsson Long terme survival in giant cell arteritis includung temporal arteritis and polymyalgia rheumatica: a follow-up study of 90 patients treated with corticosteroids Acta Med Scand 220 1986 361 364
33. J. Barrier, N. Tournemaine, D. Maulaz, B. Mainguy-Fonteneau, J. Rojouan, and G Potel Evolution, traitement et pronostic de la maladie de Horton Ann Med Interne (Paris) 134 1983 428 435
34. P.J. McDonnel, G.W. Moore, N.R. Miller, G.M. Hutchins, and W.R. Green Temporal arteritis. A clinicopathologic study Ophtalmology 93 1986 518 530
35. G.G. Hunder, D.A. Bloch, B.A. Michel, M.B. Stevens, W.P. Arend, and L.H. Calabrese The American College of Rheumatology 1990 criteria for the classification pf giant cell arteritis Arthritis Rheum 33 1990 1122 1128
36. Agence nationale d'accŕditation et d'́valuation en sant́ Prise en charge des patients adultes atteints d'hypertension art́rielle essentielle 2000 ANAES Paris
37. Agence nationale d'accŕditation et d'́valuation en sant́ Strat́gie de prise en charge du patient diab́tique de type 2 ̀ l'exclusion de la prise en charge des complications 2000 ANAES Paris
38. Agence fraņaise de ścurit́ sanitaire des aliments et des produits de sant́ Traitement ḿdicamenteux du diab̀te de type 2 1999 AFSSAPS Saint-Denis
39. Agence nationale d'accŕditation et d'́valuation en sant́ Modalit́ de d́pistage et diagnostic biologique des dyslipid́mies en pŕvention primaire 2000 ANAES Paris